Category Archives: BioUtah News
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform
Company forms new AI business unit, led by Chief Technology & AI Officer Christopher Thurston, to unify and advance Co-Dx’s existing and future AI initiatives
Health Insurance Costs 2026: Steep Increases Ahead for Employers, Including Life Sciences
Health insurance costs are projected to rise sharply in 2026
Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics
Co-Diagnostics Forms New AI Business Unit and Expands Global Footprint with CoMira Diagnostics
Owlet® Strengthens Market Leadership as Dream Sight™ Becomes the First Baby Monitor Awarded the SGS Cybersecurity Mark
Earning the first-ever SGS Cybersecurity Mark in the baby monitor category, Owlet reinforces its leadership in safety, security, privacy, and innovation.
Co-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx™ PCR Platform Across the Middle East
The new Saudi-based CoMira Diagnostics joint venture will be engaged in manufacturing and distribution of the Company’s upcoming Co-Dx™ PCR platform and other Co-Dx IP across KSA and 18 other MENA countries
EDWARDS SAPIEN 3 TAVR DELIVERS PROVEN LONG-TERM BENEFITS AND VALVE PERFORMANCE, NEW DATA PRESENTED AT TCT 2025
SAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years
SUCCESSFUL PATIENT OUTCOMES DEMONSTRATED WITH EDWARDS’ SAPIEN M3 AND EVOQUE SYSTEMS, NEW DATA PRESENTED AT TCT 2025
ENCIRCLE mitral trial achieves primary and secondary endpoints.
DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
DiscGenics and Collaborators Announce Breakthrough in Tissue-Engineered Intervertebral Disc Research
BioUtah Life Sciences Delegation Showcases Utah Innovation in Australia
As part of Governor Spencer Cox’s Australia Trade Mission from October 19–25, BioUtah led a focused Life Sciences Track highlighting Utah’s growing global leadership in biotechnology, medtech, diagnostics, and health innovation. The delegation met with prominent Australian partners, investors, and regulators to explore opportunities for collaboration and market expansion. Companies participating in the trade mission […]
Seek Labs Expands Global Disease Atlas to Include Hemorrhagic Fever Viruses
Salt Lake City, Utah – October 21, 2025 Salt Lake City-based biotech firm Seek Labs announced today that it has expanded its Global Disease Atlas™ to include several of the world’s deadliest hemorrhagic fever viruses (HFVs) — namely, Ebola virus, Marburg virus, Lassa virus, Hantavirus, Crimean‑Congo hemorrhagic fever virus (CCHFV), and Rift Valley fever virus (RVFV). In July, the company announced that it […]
Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes
LEHI, Utah, Oct. 23, 2025 /PRNewswire/ — Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes of inflammation-driven diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its investigational medicine ofirnoflast (HT-6184) for the treatment of Myelodysplastic Syndromes (MDS) — a group […]
Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite Detection
SALT LAKE CITY, October 21, 2025— ARUP Laboratories today announced the publication of an article in the Journal of Clinical Microbiology describing the company’s validation of a deep convolutional neural network (CNN) to detect parasites in concentrated wet mounts of stool. For decades, detection of gastrointestinal parasites has relied on traditional microscopy, which is a […]
